Media-OutReach Newswire As outbreak eases, home transaction volume rises to a 12-month high despite cautious market outlook
Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial